Skip to main content

pioglitazone

Generic: PIOGLITAZONE HYDROCHLORIDE·Brand: ACTOS, Actoplus Met, Actos, Duetact, Oseni, PIOGLITAZONE HYDROCHLORIDE

pioglitazone: 3 clinical trials tracked.

pioglitazone evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about pioglitazone, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 3 study sponsors

Related indications

Healthy Participants
Clinical Trials (3)

An Open-label, Fixed-sequence, Two-part Study to Assess the Effect of AZD5004 on the Pharmacokinetics of Mitiglinide and Pioglitazone in Healthy Participants

NCT07444424·Phase 1·AZN
Completed

Primary endpoint: Area under concentration-time curve from time 0 to infinity (AUCinf)

Interventionalopen32 enrolledStarted 2026-03Completion 2026-071 site · JapanAstraZeneca

Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude

NCT06164665·Phase 4·UTHR
Completed

Primary endpoint: Rate of Exogenous Glucose Oxidation

InterventionalRandomizeddouble9 enrolledStarted 2023-03Completion 2023-071 site · United StatesUnited States Army Research Institute of Environmental Medicine

A Phase II Study on Trabectedin in Combination With PPARg Agonist Pioglitazone in Patients With Round Cell Myxoid Liposarcomas or Dedifferentiated G1 and G2 Liposarcomas With Stable Disease After a Monotherapy With Trabectedin. (TRABEPIO)

NCT04794127·Phase 2·MRUS
Completed

Primary endpoint: Objective response (OR) in patients with myxoid liposarcomas according to RECIST criteria or CHOI criteria

Interventionalopen10 enrolledStarted 2022-02Completion 2024-091 site · ItalyMario Negri Institute for Pharmacological Research